Meridian Bioscience (LTS:0K0K) Stock Based Compensation : $6.9 Mil (TTM As of Sep. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Meridian Bioscience Stock Based Compensation?

Meridian Bioscience's Stock Based Compensation for the three months ended in Sep. 2022 was $1.9 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2022 was $6.9 Mil.

Meridian Bioscience Stock Based Compensation Historical Data

The historical data trend for Meridian Bioscience's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience Stock Based Compensation Chart

Meridian Bioscience Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Stock Based Compensation

Get a 7-Day Free Trial

3.40

3.25

3.80

4.16

6.90

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Stock Based Compensation	Get a 7-Day Free Trial															0.99	1.90	1.49	1.62	1.89

Meridian Bioscience Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.9 Mil.

Meridian Bioscience Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (LTS:0K0K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (LTS:0K0K) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

3471 River Hills Drive, Cincinnati, OH, USA, 45244

Website

https://www.meridianbioscience.com

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Meridian Bioscience (LTS:0K0K) Headlines

No Headlines